探索在注射[68Ga]Ga-FAPI-04后34分钟进行[18F]FDG/[68Ga]Ga-FAPI-04双低活度示踪剂一站式全身PET显像的可行性及附加价值
这项回顾性研究纳入30对疑似恶性肿瘤患者,在追加注射[68Ga]Ga-FAPI-04后34-39分钟和50-60分钟重建图像,比较一站式FDG-FAPI PET/CT与2天方案的病灶检出率和肿瘤/正常组织比值(TNR)。结果显示一站式方案病灶检出率高于2天方案,平均辐射剂量显著更低(P<0.001),注射后34分钟即可提供满足临床诊断的信息。
要点
- 一站式FDG-FAPI PET/CT在注射[68Ga]Ga-FAPI-04后34分钟即可提供满足临床诊断的信息。
- 一站式方案的病灶检出率高于2天方案。
- 一站式方案的平均辐射剂量显著低于2天方案(P<0.001)。
核心结论
- 注射[68Ga]Ga-FAPI-04后34分钟的一站式FDG-FAPI PET/CT可提供满足临床诊断的足够信息,且病灶检出率优于2天方案。
研究设计与样本
- 回顾性研究纳入30对疑似恶性肿瘤患者,均接受双示踪剂显像。
- 图像在追加注射[68Ga]Ga-FAPI-04后34-39分钟和50-60分钟重建。
- 一站式FDG-FAPI PET/CT图像命名为PETFDG、PETD34-39和PETD50-60;2天方案图像命名为PETFDG'、PETF34-39和PETF50-60。
- 分别评估各图像的病灶肿瘤/正常组织比值(TNR),并用卡方检验评估病灶检出率。
主要发现
- 在一站式FDG-FAPI PET/CT中,FAPI加权PET(PETD34-39和PETD50-60)的TNR高于PETFDG。
- PETD34-39与PETD50-60在病灶检出率和TNR上表现相似(均P>0.05)。
- 在2天方案中,PETF34-39与PETF50-60所有病灶的TNR差异无统计学意义。
- 与2天方案比较,PETF34-39的TNR显著高于PETFDG,但低于PETD34-39和PETD50-60。
- 一站式FDG-FAPI PET/CT的病灶检出率高于2天方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To validate the feasibility of one-stop 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) and [68Ga]Ga-fibroblast activation protein inhibitor-04 ([68Ga]Ga-FAPI-04) dual-low-activity-tracer positron emission tomography/computed tomography (PET/CT) at 34 min post-injection of [68Ga]Ga-FAPI-04 and explore its additional value. METHODS: Thirty pairs of patients with suspected malignancies who underwent dual-tracer imaging were enrolled in this retrospective study. The images were reconstructed at 34-39 and 50-60 min after additional injection of [68Ga]Ga-FAPI-04 (in one-stop FDG-FAPI PET/CT, named PETFDG, PETD34-39, and PETD50-60; in the 2-day protocol, named PETFDG', PETF34-39, and PETF50-60, respectively). Tumour-to-normal ratios (TNR) of lesions in PETFDG, PETD34-39, and PETD50-60 and TNR of lesions in PETF34-39 and PETF50-60 were evaluated separately. To evaluate the potential added value of one-stop FDG-FAPI PET/CT over the 2-day protocol, TNRs of PETFDG, PETD34-39, and PETD50-60 were compared with PETF34-39. The lesion detectability of the two imaging protocols was evaluated by chi-square test. RESULTS: Comparing FAPI-weighted PET (PETD34-39 and PETD50-60) and single-tracer imaging (PETFDG) in one-stop FDG-FAPI PET/CT, TNRs of FAPI-weighted PET were higher than those of PETFDG. PETD34-39 and PETD50-60 showed similar performance in lesion detectability and TNRs (all P > 0.05). In the 2-day protocol, there are no statistically significant differences in TNRs of all lesions at PETF34-39 and PETF50-60. Comparing one-stop FDG-FAPI PET/CT with the 2-day protocol, TNRs of PETF34-39 were significantly higher than those of PETFDG but lower than those of PETD34-39 and PETD50-60. Lesion detectability in the one-stop FDG-FAPI PET/CT was higher than that in the 2-day protocol. The average radiation dose in one-stop FDG-FAPI PET/CT was significantly lower than that in the 2-day protocol (P<0.001). CONCLUSION: One-stop FDG-FAPI PET/CT at 34 min could provide sufficient information to meet clinical diagnosis and showed better lesion detectability than that in the 2-day protocol.
引用
- Zheng Z, He Y, Mao W, et al. Exploration the feasibility and additional value of [18F]FDG/[68Ga]Ga-FAPI-04 dual-low-activity-tracer one-stop total-body PET imaging at 34 min post-injection of [68Ga]Ga-FAPI-04. Eur J Nucl Med Mol Imaging. 2024. PMID: 39320482. doi:10.1007/s00259-024-06924-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。